期刊文献+

卡维地洛控释胶囊及其临床研究进展 被引量:1

下载PDF
导出
摘要 目的:综述利用微泵技术制成的卡维地洛控释胶囊的临床药动学及临床研究特点,以及国外多中心继续研究情况。方法:检索近年来卡维地洛控释胶囊的国内外相关文献并进行总结。结果:卡维地洛控释胶囊可以使有效血药浓度维持24h,每天一次给药与卡维地洛片与每天2次给药有相同的药动学参数和抗高血压效果。结论:卡维地洛控释胶囊与卡维地洛片具有生物等效性,用于高血压、心绞痛及心衰的治疗可提高患者顺应性,正在进行的新研究将进一步拓宽控释剂型的应用空间,该新制剂具有广阔的市场前景。
作者 李霞 邓树海
机构地区 山东大学药学院
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2007年第9期1282-1284,共3页 Chinese Journal of Hospital Pharmacy
  • 相关文献

参考文献10

  • 1杨田,沈萍,赵仙先.卡维地洛药理作用的研究进展[J].心血管病学进展,2003,24(2):110-113. 被引量:50
  • 2陈新谦.新编药物学[M](第15版)[M].北京:人民卫生出版社,2004.48.
  • 3Tenero DM,Henderson LS,Baidoo CA,et al.Pharmacokinetic Properties of a New Controlled-Release Formulation of Carvedilol[J].Am J Cardiol,2006,98:5L-16L.
  • 4Henderson LS,Tenero DM,Baidoo CA,et al.Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension[J].Am J Cardiol,2006,98:17L-26L.
  • 5Weber MA,Sica DA,Tarka EA,et al.Controlled-release carvedilol in the treatment of essential hypertension[J].Am J Cardiol,2006,98(suppl):32L-38L.
  • 6Packer M,Lukas MA,Tenero DM,et al.Pharmacokinetic profile of controlled-release carvedilol in patients with left ventricular dysfunction associated with chronic heart failure or after myocardial infarction[J].Am J Cardiol,2006,98:39L-45L.
  • 7Weber MA,Bakris GL,Tarka EA,et al.Efficacy of a oncedaily formulation of carvedilol for the treatment of hypertension[J].J Clinic Hypertension,2006,8:840-849.
  • 8Greenberg BH,Mehra M,Teerlink JR,et al.COMPARE:Comparison of the effects of carvedilol CR and carvedilol IR on left ventricular ejection fraction in patients with heart Failure[J].Am J Cardiol,2006,98:53L-59L.
  • 9Hauptman PJ,Pressler SJ,Sackner-Bernstein J,et al.Rationale and design of CASPER:compliance and quality of life study comparing once-daily carvedilol CR and twice-daily carvedilol IR in patients with heart failure[J].Am J Cardiol,2006,98:60L-66L.
  • 10Bakris GL,Tarka EA,Waterhouse B,et al.Cardiovascular risk factors in hypertension:rationale and design of studies to investigate the effects of controlled-release carvedilol on regression of left ventricular hypertrophy and lipid profile[J].Am J Cardiol,2006,98:46L-52L.

二级参考文献24

  • 1[11]Santos DJ, Moreno AJ. Inhibition of heart mitochondrial lipid peroxidation by non-toxic concentrations of carvedilol and its analog BM-910228 [J]. Biochem Pharmacol ,2001,61 (2): 155-164.
  • 2[12]Noguchi N, Nishino K,Niki E. Antioxidant action of the antihypertensive drug,carvedilol, against lipid peroxidation [J]. Biochem Pharmacol, 2000, 59 ( 9 ):1069-1076.
  • 3[13]Rossig L, Haendeler J, Mallat Z, et al. Congestive heart failure induces endothelial cell apoptosis :protective role of carvedilol [J]. J Am Coll Cardilo,2001 ,36( 7 ) :2081-2089.
  • 4[14]Romeo F,LiM D,Shi M ,et al. Carvedilol prevents epinephrine-induced apoptosis in human coronary artery endothelial cells:modulation of Fas/Fsa ligand and caspase-3 pathway [ J ]. Cardiovasc Res, 2000,45 ( 3 ) :788-794.
  • 5[15]Cao F,Chen J,Lopez BL,et al. Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model [ J ]. Eur J Pharmacol,2000,406( 1 ) :109-116.
  • 6[16]Wei S.Chow LT,Sanderson JE,et al. Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction[J]. J Am Coll Cardiol.2000,36( 1 ) :276-281.
  • 7[17]Ohta Y, Watanabe K, Nakazawa M,et al. Carvedilol enhances atrial and brain natriuretic peptide mRNA expression and release in rat heart[ J ]. J Cardiovasc Pharmacol,2000,36 ( suppl 2 ) 19-23.
  • 8[18]Savitz SI, Erhardt JA, Anhtony JV, et al. The novel β-bolcker, carvedilol, provides neuroprotection in transient focal stroke[J]. J Cereb Blood Flow Metab,2000,20(8) :1197-1204.
  • 9[19]Karle CA, Kreye VA,Thomas D, et al. Antarrhythmic drug carvedilol inhibits HERG potassium channels [ J ]. Cardiovasc Res,2001,49 ( 2 ): 361-370.
  • 10[20]Takusagawa M, Komori S, Matsumura K, et al. The inhibitory effects of carvedilol against arhytmias induced by coronary by coronary reperfusion in aneothetized rats [J]. J Cardiovasc Pharmacol Ther, 2000, 5 ( 2 ): 105 - 112.

共引文献134

同被引文献6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部